DNP 019
Alternative Names: DNP-019Latest Information Update: 30 Oct 2020
At a glance
- Originator DiNonA
- Class Antibodies; Antivirals
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research COVID 2019 infections
Most Recent Events
- 20 Oct 2020 Early research in COVID-2019 infections in South Korea (Parenteral) before October 2020